Persistence of Mortality Reduction After the End of Randomized Therapy in Clinical Trials of Blood Pressure–Lowering Medications-Reference-Cited by-同舟云学术

Persistence of Mortality Reduction After the End of Randomized Therapy in Clinical Trials of Blood Pressure–Lowering Medications

Published:2010-12 Issue:6 Volume:56 Page:1060-1068
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Kostis William J.¹,Thijs Lutgarde¹,Richart Tom¹,Kostis John B.¹,Staessen Jan A.¹

Affiliation:

1. From the Cardiology Division (W.J.K.), Massachusetts General Hospital, Boston, Mass; Division of Hypertension and Cardiac Rehabilitation (L.T., T.R., J.A.S.), Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Department of Medicine (J.B.K.), University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference47 articles.

1. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

2. Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents

3. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

4. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men

5. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial;European Heart Journal;2024-01-31

2. The long-term benefits of early intensive therapy in chronic diseases—the legacy effect;Clinical Kidney Journal;2023-08-10

3. Comprehensive approach to a patient with arterial hypertension and dyslipidemia;Vnitřní lékařství;2022-10-03

4. Antihypertensive drug class in combination with lipid lowering treatment for primary prevention of cardiovascular disease in the elderly;Heart & Lung;2022-01

5. Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies?;Antioxidants;2021-11-22